eBook
The Billion-Dollar Blind Spot: How Scite's Contextual Research Analysis Protects Pharmaceutical Investments
Our comprehensive eBook reveals how Scite's contextual research analysis platform helps pharmaceutical companies identify contradictory research early, potentially saving billions in failed clinical trials and—most importantly—preventing patient harm.
Download NowWith scientific research output doubling every nine years and spread across 40,000+ journals, traditional literature review methods can't keep pace. The significant time lag between original publications and contradictory findings—often two to five years—creates a critical window where pharmaceutical companies might proceed with development based on incomplete evidence.
Inside This Critical Industry Report:
- Alarming Statistics: Only 7.9% of drug candidates entering clinical trials ultimately receive FDA approval, with each approved drug costing an average of $2.8 billion to develop
- Real-World Case Study: Follow the USP14 inhibition research timeline—from initial promise to devastating clinical trial failure—and discover how advanced citation analysis could have prevented significant investment losses and patient harm
- Strategic Implementation Guide: Learn how pharmaceutical companies can integrate Scite's capabilities at multiple stages of the development pipeline, from target validation to portfolio management
- ROI Analysis: Quantify the multi-dimensional value of better research intelligence, including direct savings, opportunity cost reduction, faster time-to-market, and enhanced regulatory outcomes
Fill out the form and access your free eBook!